SPONSOR
Shanghai Zhongshan Hospital
Total Trials
13
Recruiting
13
Phases
Phase 2, Phase 2, Phase 3, Phase 1, Phase 2
Conditions studied: MyopiaGastric CancerGastroEsophageal CancerAcute Myocardial Infarction (AMI)Aortic Valve StenosisImpact of Sleep Disorders on Tumor Immune Microenvironment and Clinical Outcomes in Lung CancerGastric or Gastroesophageal Junction AdenocarcinomaEsophageal Squamous Cell CarcinomaCoronary CalcificationIrritable Bowel Syndrome
Shanghai Zhongshan Hospital is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Myopia, Gastric Cancer, GastroEsophageal Cancer, Acute Myocardial Infarction (AMI).
The trial portfolio spans Phase 2, Phase 2, Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Zhongshan Hospital
How many clinical trials has Shanghai Zhongshan Hospital sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by Shanghai Zhongshan Hospital, of which 13 are actively recruiting participants. These trials cover conditions including Myopia, Gastric Cancer, GastroEsophageal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Zhongshan Hospital research focus on?
Shanghai Zhongshan Hospital clinical trials span Myopia, Gastric Cancer, GastroEsophageal Cancer, Acute Myocardial Infarction (AMI), Aortic Valve Stenosis, and additional conditions. The research pipeline includes Phase 2, Phase 2, Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Zhongshan Hospital clinical trial?
To participate in a Shanghai Zhongshan Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Zhongshan Hospital trials with current recruitment status updated daily.
Clinical Trials by Shanghai Zhongshan Hospital
NCT06992011
Recruiting
A Randomized Controlled Trial Comparing Clinical Effectiveness of SMILE Versus SMILE Xtra in Myopia
Myopia
NCT06468280 Phase 2
Recruiting
Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer
Gastric Cancer
NCT07400601
Recruiting
A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at Zhongshan Hospital
Acute Myocardial Infarction (AMI)
NCT07145463
Recruiting
Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions
Aortic Valve Stenosis
NCT06941948
Recruiting
Sleep Disorders and Tumor Immune Microenvironment
Impact of Sleep Disorders on Tumor Immune Microenvironment and Clinical Outcomes in Lung Cancer
NCT06587425 Phase 2
Recruiting
The Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced, Recurrent, or Metastatic CLDN18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
Gastric or Gastroesophageal Junction Adenocarcinoma
NCT06637163 Phase 2
Recruiting
Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC
Esophageal Squamous Cell Carcinoma
NCT07277114
Recruiting
DCB vs DES for Severe Coronary Calcification After Optimal Modification Assessed by QFR
Coronary Calcification
NCT05740319
Recruiting
Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
Irritable Bowel Syndrome
NCT04973306 Phase 2, Phase 3
Recruiting
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
Esophageal Squamous Cell Carcinoma Stage II
NCT06519656 Phase 1, Phase 2
Recruiting
Efficacy of Mazdutide for Treating PCOS
Polycystic Ovary Syndrome
NCT05740995
Recruiting
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
NCT07241533
Recruiting
Asiaticoside for Treating Overweight/Obesity
Overweight , Obesity
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology